Holen Sie sich die Stockscreener-App
16.01
0.69%
0.11
Handel nachbörslich:
16.01
Schlusskurs vom Vortag:
$15.90
Offen:
$15.9
24-Stunden-Volumen:
79,465
Relative Volume:
0.58
Marktkapitalisierung:
$150.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.17M
KGV:
-1.5798
EPS:
-10.1344
Netto-Cashflow:
$-82.84M
1W Leistung:
+17.12%
1M Leistung:
+34.09%
6M Leistung:
-57.08%
1J Leistung:
-69.38%
1-Tages-Spanne:
$15.26
$16.47
1-Wochen-Bereich:
$12.76
$17.82
52-Wochen-Spanne:
$10.29
$98.00
Korro Bio Inc Stock (KRRO) Company Profile
Firmenname
Korro Bio Inc
Sektor
Branche
Telefon
617-468-1999
Adresse
60 FIRST STREET, CAMBRIDGE
Vergleichen Sie KRRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
16.01 | 149.31M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-16 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-01-10 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2024-08-14 | Eingeleitet | William Blair | Outperform |
| 2024-03-28 | Bestätigt | H.C. Wainwright | Buy |
| 2024-02-27 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-11-10 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-15 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-09-22 | Herabstufung | Goldman | Buy → Neutral |
| 2021-01-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
| 2020-07-14 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-10-28 | Eingeleitet | Cowen | Outperform |
| 2019-10-28 | Eingeleitet | Goldman | Buy |
| 2019-10-28 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Korro Bio Inc Aktie (KRRO) Neueste Nachrichten
What are analysts’ price targets for Korro Bio Inc. in the next 12 monthsCapitalize on strong market momentum - jammulinksnews.com
How strong is Korro Bio Inc. company’s balance sheetAchieve breakthrough financial results today - jammulinksnews.com
How many analysts rate Korro Bio Inc. as a “Buy”Maximize your gains with expert trading tips - jammulinksnews.com
What institutions are buying Korro Bio Inc. stock nowTriple Digit Return Forecasts - Newser
What makes Korro Bio Inc. stock price move sharplyCapital Growth Picks - Newser
Korro Bio Inc. Company’s Quarterly Earnings Growth: What the Numbers SaySmart High Yield Swing Trades - Newser
What are Korro Bio Inc. company’s key revenue driversInvest smarter with expert stock picks - jammulinksnews.com
Sectors Driving Future Growth for Korro Bio Inc. StockHigh Return Conservative Stocks - Newser
Will Korro Bio Inc. stock split in the near futureProven Trading Plan - Newser
Is Korro Bio Inc. a Top Dividend Stock to Watch in 2025Short Term Profit Focus - Newser
What makes Korro Bio Inc. stock attractive to long term investorsFree Financial Group - Newser
Korro Bio’s (KRRO) “Buy” Rating Reiterated at HC Wainwright - Defense World
What risks could impact Korro Bio Inc. stock performanceFree Risk Assessment Services - Newser
Why Korro Bio Inc. stock attracts strong analyst attentionPrecision Entry Strategy - Metal.it
What analysts say about Korro Bio Inc. stockFree Expert Stock Watchlist - PrintWeekIndia
Korro Bio Inc. Stock Analysis and ForecastFree Consultation - PrintWeekIndia
H.C. Wainwright reiterates Buy rating on Korro Bio stock with $100 target - Investing.com India
Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Rating of “Buy” by Brokerages - Defense World
Is Korro Bio Inc. a good long term investmentRapidly growing investment returns - jammulinksnews.com
Korro Bio stock steady as H.C. Wainwright reiterates Buy rating - Investing.com
Buy Rating for Korro Bio Driven by Promising KRRO-110 and Orphan Drug Designation - TipRanks
Korro Bio receives EMA orphan drug designation for AATD treatment By Investing.com - Investing.com South Africa
Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110 - The Manila Times
Korro Bio receives EMA orphan drug designation for AATD treatment - Investing.com
Korro Achieves Crucial EMA Orphan Drug Status for AATD Treatment, Following FDA Recognition - Stock Titan
What drives Korro Bio Inc. stock priceTremendous growth potential - jammulinksnews.com
How Korro Bio Inc. stock performs during market volatilityFree Access to Community - Newser
Finanzdaten der Korro Bio Inc-Aktie (KRRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):